Stock listing
LTRN Stock Price, News, Filings & Events — Lantern Pharma Inc.
Selected listing: LTRN · NASDAQ · USD · US
LTRN:NASDAQ is the public listing for Lantern Pharma Inc., a company dedicated to developing targeted cancer therapies. With a market capitalization of around $35 million, Lantern Pharma utilizes its proprietary technology to enhance treatment outcomes for patients battling cancer. The company is actively engaged in advancing its pipeline and may release updates on its research and development efforts, filings, and market activities.
- Ticker
- LTRN:NASDAQ
- Asset type
- Stock
- Market cap
- $36.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Lantern Pharma Inc. LTRN:NASDAQ stock context
LTRN:NASDAQ is the public listing for Lantern Pharma Inc., a company dedicated to developing targeted cancer therapies. With a market capitalization of around $35 million, Lantern Pharma utilizes its proprietary technology to enhance treatment outcomes for patients battling cancer. The company is actively engaged in advancing its pipeline and may release updates on its research and development efforts, filings, and market activities.
Research Lantern Pharma Inc.
Lantern Pharma Inc. investor report
Review AI stock analysis and investor report context for LTRN:NASDAQ.
Lantern Pharma Inc. company profile
View the public company page for Lantern Pharma Inc. on 6ix.
Lantern Pharma Inc. news
Read company news and market updates connected to Lantern Pharma Inc..
Lantern Pharma Inc. investor events
Find investor webinars, events, and replay context for Lantern Pharma Inc..